SAN ANTONIO, October 16, 2024--bioAffinity VP served on expert panel to update flow cytometry guidelines for unique ...

Affinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shares traded up 1.9% during trading on Tuesday . The company traded as high as $1.58 and last traded at $1.09. 18,856 shares traded hands ...

Edwards will report directly to bioAffinity Technologies President and CEO Maria Zannes. "We are delighted to welcome Michael ...

Affinity Technologies has appointed J. Michael Edwards as Chief Financial Officer. Takeaway Points bioAffinity Technologies ...

Affinity Technologies today announced it appointed J. Michael Edwards as chief financial officer in September.

Affinity Technologies' CyPath® Lung test will be added to the Federal Supply Schedule to help veterans and active military at ...

More doctors are ordering bioAffinity Technologies' CyPath Lung test and sales are skyrocketing. A long-term military health ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that J. Michael ...

The screening method developed by bioAffinity Technologies Inc. uses AI-aided computer analysis of a patient’s phlegm in a test that can spot lung cancer in high-risk patients earlier than other ...

SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a biotech firm engaged in developing noninvasive tests for early-stage cancer detection, has appointed J. Michael Edwards as its ...

SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a biotech firm engaged in developing noninvasive tests for early-stage cancer detection, has appointed J. Michael Edwards as its ...